379 related articles for article (PubMed ID: 16891642)
21. Once-monthly darbepoetin alfa for maintaining hemoglobin levels in older patients with chronic kidney disease.
Agarwal A; Silver MR; Walczyk M; Liu W; Audhya P
J Am Med Dir Assoc; 2007 Feb; 8(2):83-90. PubMed ID: 17289537
[TBL] [Abstract][Full Text] [Related]
22. Intravenously administered darbepoetin alfa once a week could maintain hemoglobin level more efficiently than once every 2 weeks in patients on hemodialysis.
Nagaya H; Inaguma D; Kitagawa A; Murata M; Kamimura Y; Hamaguchi K; Tatematsu M; Suzuki S; Kurata K; Yuzawa Y; Matsuo S
Clin Exp Nephrol; 2010 Apr; 14(2):158-63. PubMed ID: 19967423
[TBL] [Abstract][Full Text] [Related]
23. Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients.
Nissenson AR; Swan SK; Lindberg JS; Soroka SD; Beatey R; Wang C; Picarello N; McDermott-Vitak A; Maroni BJ
Am J Kidney Dis; 2002 Jul; 40(1):110-8. PubMed ID: 12087568
[TBL] [Abstract][Full Text] [Related]
24. [Evolution of the darbepoetin alpha resistance index in patients on dialysis who change from weekly to fortnightly treatments in clinical practice].
López-Gómez JM; de Francisco AL; Montenegro J; de Santiago C; Vera M; Donapetry C; Villaverde M
Nefrologia; 2010; 30(1):64-72. PubMed ID: 20098471
[TBL] [Abstract][Full Text] [Related]
25. A comparison of haemoglobin levels and doses in haemodialysis patients treated with subcutaneous or intravenous darbepoetin alfa: a German prospective, randomized, multicentre study.
Bommer J; Asmus G; Wenning M; Bommer G
Nephrol Dial Transplant; 2008 Dec; 23(12):4002-8. PubMed ID: 18676350
[TBL] [Abstract][Full Text] [Related]
26. Darbepoetin alpha in lower-than-equimolar doses maintains haemoglobin levels in stable haemodialysis patients converting from epoetin alpha/beta.
Bock HA; Hirt-Minkowski P; Brünisholz M; Keusch G; Rey S; von Albertini B;
Nephrol Dial Transplant; 2008 Jan; 23(1):301-8. PubMed ID: 17890745
[TBL] [Abstract][Full Text] [Related]
27. C.E.R.A. maintains stable control of hemoglobin in patients with chronic kidney disease on dialysis when administered once every two weeks.
Spinowitz B; Coyne DW; Lok CE; Fraticelli M; Azer M; Dalal S; Villa G; Rosansky S; Adamis H; Beyer U;
Am J Nephrol; 2008; 28(2):280-9. PubMed ID: 18004064
[TBL] [Abstract][Full Text] [Related]
28. Every-other-week darbepoetin alfa in the correction and maintenance of haemoglobin levels in elderly patients with chronic kidney disease: post hoc subanalysis of data from two clinical trials.
Krause MW; Raja R; Agarwal A; Silver MR; Scarlata D; Sciarra A; Kewalramani R
Drugs Aging; 2009; 26(8):665-75. PubMed ID: 19685932
[TBL] [Abstract][Full Text] [Related]
29. Darbepoetin alfa administered monthly maintains haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis: a multicentre, open-label, Australian study.
Disney A; Jersey PD; Kirkland G; Mantha M; Charlesworth JA; Gallagher M; Harris D; Gock H; Mangos GJ; Macmillan J; Liu W; Viswalingam A
Nephrology (Carlton); 2007 Feb; 12(1):95-101. PubMed ID: 17295668
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of renal anemia with darbepoetin alfa administered once every other week in predialysis patients with chronic kidney disease and previously treated with epoetin alfa].
Molina M; García Hernández MA; Navarro MJ; Pérez Silva F; Cacho M; De Gracia MC
Nefrologia; 2004; 24(1):54-9. PubMed ID: 15083958
[TBL] [Abstract][Full Text] [Related]
31. Darbepoetin alfa administration to achieve and maintain target hemoglobin levels for 1 year in patients with chronic kidney disease.
Hertel JE; Locay HR; Scarlata DS; Prathikanti R; Audhya PK
Mayo Clin Proc; 2006 Sep; 81(9):1188-94. PubMed ID: 16970215
[TBL] [Abstract][Full Text] [Related]
32. Preference for monthly darbepoetin alfa dosing in patients with chronic kidney disease not receiving dialysis.
Hoggard J; Crouch T; McMurray S; Levine M; Prathikanti R; Scarlata D; Audhya P
Curr Med Res Opin; 2006 Oct; 22(10):2023-30. PubMed ID: 17022861
[TBL] [Abstract][Full Text] [Related]
33. Extended epoetin alfa dosing in chronic kidney disease patients: a retrospective review.
Germain M; Ram CV; Bhaduri S; Tang KL; Klausner M; Curzi M
Nephrol Dial Transplant; 2005 Oct; 20(10):2146-52. PubMed ID: 15985516
[TBL] [Abstract][Full Text] [Related]
34. Randomized trial to compare the dosage of darbepoetin alfa by administration route in haemodialysis patients.
Kim CD; Park SH; Kim DJ; Park JW; Do JY; Shin SK; Kim BS; Seo JJ; Kim YL
Nephrology (Carlton); 2009 Aug; 14(5):482-7. PubMed ID: 19298639
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
[TBL] [Abstract][Full Text] [Related]
36. What is the practical conversion dose when changing from epoetin alfa to darbepoetin outside of clinical trials?
Roger SD; Cooper B
Nephrology (Carlton); 2004 Aug; 9(4):223-8. PubMed ID: 15363054
[TBL] [Abstract][Full Text] [Related]
37. Change in darbepoetin alfa administration schedule affects erythropoiesis-stimulating agent resistance in patients with chronic kidney disease receiving hemodialysis.
Molina M; Navarro MJ; de Gracia C; Alvarez G; de Alarcon R; Garcia MA
Ren Fail; 2008; 30(8):778-83. PubMed ID: 18791951
[TBL] [Abstract][Full Text] [Related]
38. Parameters for successful monthly extended dosing of darbepoetin-alpha in patients undergoing hemodialysis.
Trachsler J; Glück Z; Dickenmann M; Gauthier T; Brünisholz M; Martin PY; Burnier M; Wahl C; Wüthrich RP
Clin Nephrol; 2009 Jun; 71(6):697-702. PubMed ID: 19473639
[TBL] [Abstract][Full Text] [Related]
39. Subcutaneous administration of darbepoetin alfa effectively maintains hemoglobin concentrations at extended dose intervals in peritoneal dialysis patients.
Fang YW; Chang CH
Perit Dial Int; 2009; 29(2):199-203. PubMed ID: 19293358
[TBL] [Abstract][Full Text] [Related]
40. Effect of darbepoetin alfa administered once monthly on maintaining hemoglobin levels in older patients with chronic kidney disease.
Silver MR; Agarwal A; Krause M; Lei L; Stehman-Breen C
Am J Geriatr Pharmacother; 2008 Jun; 6(2):49-60. PubMed ID: 18675764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
